Hypouricemia and cancer

Oncology (Switzerland)

Volumn 53, Issue 4, 1996, Pages 345-348

  Morales, Manuel ^a   Garcia Nieto, Victor ^b  

^a Department of Medicine   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

Benzbromarone; Hypouricemia; Pyrazinamide suppression test; Renal transport of; Urate

Indexed keywords

BENZBROMARONE; PYRAZINAMIDE; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION; HUMAN; HYPOURICEMIA; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZBROMARONE; BREAST NEOPLASMS; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; NEOPLASM METASTASIS; PYRAZINAMIDE; RETROPERITONEAL NEOPLASMS; SARCOMA; URIC ACID;

EID: 0029975312     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227585     Document Type: Article

References (36)

1. Ramsdell CM, Kelley WN: The clinical significance of hypouricemia, Ann Intern Med 1973; 78:239-242.
2. Casas E, Serrano C, Daimiel E, Michán A, Mateos F, García Puig J: Prevalencia, fisiopa-thología y procesos asociados a hipouricemia en una población hospitalaria: análisis de 27.987 determinaciones analíticas, Rev Clin Esp 1990;186:211-215.
3. Gaspar G, Martínez ME, Lisbona A, et al: Hipouricemia y carcinoma medular de tiroides, Mcd Clin 1982;79:464-467.
4. Puig JG, Mateos AF, Gaspar G, Martínez EM, Ramos T, Lcsmes A: Hypouricemia and medullary carcinoma of the thyroid, Adv Exp Med Biol 1984:165:211-213.
5. Cooper DS: Oat-cell carcinoma and severe hypouricemia, N Engl J Med 1973;288:321-322.
6. Moriwaki Y, Yamamoto T, Takahashi S, Na-kano T, Amuro Y, Hada T: A case of primary hepatocellular carcinoma with hypouricemia, Nippon Naika Gakkai Zasshi 1986:75:1769-1773.
7. Magoula I, Tsapas G, Garyfallos A, Kountou-ras J: Hypouricemia in liver cell carcinoma: An isolated renal tubular defect, Am J Med 1987; 83:196-197.
8. Magoula I, Tsapas G, Kountouras Paletas K: Cholangiocarcinoma and severe renal hypouricemia: A study of the renal mechanisms, Am J Kidney Dis 1991;18:514-519.
9. Gato Diez A, Alonso-Vega GG; Garcia Vela JA, Montans Araujo J: Tumor pancreático multisecretor e hipouricemia asociada, Med Clin 1992:98:118.
10. Bennett JS, Bond J, Singer I, Gottlieb AJ: Hypouricemia in Hodgkin’s disease, Ann Intern Mcd 1972;76:751-756.
11. Kay NE, Gottlieb AJ: Hypouricemia in Hodgkin's disease, Cancer 1973;32:1508-1511.
12. Vemant JP, Zittoun R: Hypo-uricémic dans la maladie de Hodgkin, Nouv Pressc Mcd 1975:4: 2111.
13. Zamkoff K, Kaplan M, Gottlieb AJ: Hypouricemia in Hodgkin’s disease, Relation to extent of disease, NY State J Med 1978:78:1047-1049.
14. Muñoz-Sanz A, Barbado FJ, Peña JM, ct al: Hipouricemia paraneoplásicacn cl linfoma dc Hodgkin por defecto en la reabsorción tubular postsccrctora del ácido úrico, Med Clin 1981: 76:307-310.
15. Tykarski A: Mechanism of hypouricemia in Hodgkin's disease, Nephron 1988:50:217-219.
16. Dwosh I, Roncari DAK, Marliss E, Fox HI: Hypouricemia in diseases: A study of different mechanisms, J Lab Clin Med 1977:90:153-161.
17. Gaspar GA-V, Puig JG, Mateos FA, Oria CR, Gómez MEM, Gil AA: Hypouricemia due to renal urate wasting: Different types of tubular transport defects, Adv Exp Med Biol 1986; 195A:357-363.
18. Uchida S, Matsuda O, Yokota T, et al: Adult Fanconi syndrome secondary to k-light chain myeloma: Improvement of tubular functions after treatment for myeloma, Nephron 1990; 55:332-335.
19. Afzal Mir M, Delamorc IW: Hypouricaemia and proximal renal tubular dysfunction in acute myeloid leukaemia, Br Med J 1974;iii: 775-777.
20. Mitnick PD, Beck LH: Hypouricemia and malignant neoplasms, Arch Intern Med 1979:139: 1186-1187.
21. Kitamura T, Homma Y, Nishimura Y: A case of familial renal hypouricemia associated with renal cancer, Nippon Hinyokika Gakkai Zasshi 1984:75:310-315.
22. Ames BN, Cathcart R, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis, Prod Natl Acad Sci USA 1981;78:6858-6862.
23. Sies H: Oxidative stress; Introductory remarks; in Sies H (ed): Oxidative Stress, New York, Academic Press, 1985. pp 1-8.
24. Lesko SA: Chemical carcinogenesis: Benzopy-rene system, Methods Enzymol 1984; 105:539-550.
25. Osterlind K, Hansen HH, Hansen M, Domber-nowsky P: Long-term disease-free survival in small-cell carcinoma of the lung: A study of clinical determinants, J Clin Oncol 1986;4: 1307-1313.
26. Lucagne P, Fallourd P, Redelspergcr PY, Cour-tin A, Libeskind M: Syndrome de Schwartz-Bar, ter avee hypo-uriccmie du ä une tumeur tracheale anaplasique ä petitcs cellules, Nouv Presse Med 1980:37:2739.
27. Weinberger A, Santo M, Solomon F, Shalit M, Pinkhas J, Sperling O: Abnormality in renal urale handling in the syndrome of inappropiate secretion of antidiuretic hormone, Isr J Med Sci 1982;18:711-713.
28. Passamonte PM: Hypouricemia, inappropiate secretion of antidiurctic hormone, and small cell carcinoma of the lung, Arch Intern Med 1984:144:1569-1570.
29. Sorensen JB, Osterlind K, Kristjansen PE, Hammer M, Hansen M: Hypouricemia and urate excretion in small cell lung carcinoma patients with syndrome of inappropriate antidiuresis, Acta Oncol 1988;27:351-355.
30. Steele TH, Rieselbach RE: The renal mechanism for urate homeostasis in man, Am J Med 1967:43:868-875.
31. Colussi G, Rombola G, De Ferrari ME, et al: Pharmacological evaluation of urate handling in humans: Pyrazinamidc test vs combined py-razinamide and probenecid administration, Nephrol Dial Transplant 1987;2:10-16.
32. Diamond H: Interpretation of pharmacologic manipulation of urate transport in man, Nephron 1989:51:1-5.
33. Tofuku Y, Kuroda M, Tkeda R: Hypouricemia due to renal urate wasting, Nephron 1982:30: 39-44.
34. Weiner IM, Tinker JP: Pharmacology of pyrazinamidc: Metabolic and renal function studies related to the mechanism of drug-induced urale retention, J Pharmacol Exp Thcr 1972; 180:411-434.
35. Guggino SE, Aronson PS: Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog microvillus membranes, J Clin Invest 1985;76:543-547.
36. Kahn AM, Wciman EJ: Urate transport in the proximal tubule: In vivo and vesicle studies, Am J Physiol 1985;249:789-798.